loader
Please Wait
Applying Filters...

Annual Sales of (3R,11S)-6-fluoro-3,11-dimethyl-10-oxa-2,13,17,18,21-pentazatetracyclo[13.5.2.04,9.018,22]docosa-1(21),4(9),5,7,15(22),16,19-heptaen-14-one reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Augtyro

PharmaCompass

01

Brand Name : Augtyro

Repotrectinib

arrow
World Dairy Expo 2024
Not Confirmed

Brand Name : Augtyro

arrow
World Dairy Expo 2024
Not Confirmed

Repotrectinib

Main Therapeutic Indication : Oncology

Currency : USD

2023 Revenue in Millions : 1

2022 Revenue in Millions : 0

Growth (%) : New Launch

blank